Arix Bioscience (ARIX)

Sector:

Financials

112.50p
   
  • Change Today:
    -1.50p
  • 52 Week High: 125.00
  • 52 Week Low: 97.00
  • Currency: UK Pounds
  • Shares Issued: 129.39m
  • Volume: 121,064
  • Market Cap: £145.56m
  • Beta: 0.32

ARIX Overview

Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -26035.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a 0.0
PEG n/a n/a
Pr/Revenue 1299.7 n/a
Pr/Book 0.6  
Latest F'cast
Revenue 3163.4% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ARIX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 51.17 42.76 32.10p 5.2 n/a n/a n/a 0.0%
31-Dec-19 0.51 (75.57) (53.80)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.48 126.30 96.60p 2.3 n/a n/a n/a 0.0%
31-Dec-21 0.34 (61.08) (0.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.11 (27.58) (23.90)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ARIX Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 n/a n/a 18,815.50p 0.0 n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Latest ARIX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ARIX Market Data

Currency UK Pounds
Share Price 112.50p
Change Today -1.50p
% Change -1.32 %
52 Week High 125.00
52 Week Low 97.00
Volume 121,064
Shares Issued 129.39m
Market Cap £145.56m
Beta 0.32

ARIX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.20% above the market average78.20% above the market average78.20% above the market average78.20% above the market average78.20% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Price Trend
64.90% above the market average64.90% above the market average64.90% above the market average64.90% above the market average64.90% above the market average
60.66% above the sector average60.66% above the sector average60.66% above the sector average60.66% above the sector average60.66% above the sector average
Income Not Available
Growth
64.81% above the market average64.81% above the market average64.81% above the market average64.81% above the market average64.81% above the market average
57.80% above the sector average57.80% above the sector average57.80% above the sector average57.80% above the sector average57.80% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ARIX Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
11:56 100,000 @ 112.00p
16:35 4,985 @ 112.50p
16:35 2,485 @ 112.50p
16:35 2,500 @ 112.50p
16:23 2,850 @ 114.45p

ARIX Key Personnel

Chair Peregrine D E M Moncreiffe
CEO Robert Lyne

Top of Page